Literature DB >> 19020884

The impact of positive soft tissue surgical margins following radical cystectomy for high-grade, invasive bladder cancer.

Pantelis Hadjizacharia1, John P Stein, Jie Cai, Gus Miranda.   

Abstract

INTRODUCTION: We evaluate the incidence and risk factors associated with positive soft tissue surgical margins (STSM) and determine the association with various surgical and pathological characteristics and clinical outcomes in patients undergoing radical cystectomy (RC) for bladder cancer. PATIENTS AND METHODS: From November 1971 to December 2005, 1,591 patients with primary transitional cell carcinoma (TCC) of the bladder underwent RC, with an extended bilateral pelvic lymphadenectomy and urinary diversion. A positive STSM was defined as tumor identified at the inked perivesical soft tissue surrounding the cystectomy specimen. Data were analyzed according to various clinical and pathologic variables, and survival analysis was performed.
RESULTS: A total of 18 patients (1%) demonstrated pathologic evidence of a positive STSM following RC. Positive STSM were significantly associated with lymphovascular invasion, advanced pathologic stage, lymph node involvement, extent of nodal involvement and lymph node density. No patient with an organ-confined primary bladder tumor had a positive STSM, while 3% with extravesical tumor extension demonstrated a positive STSM. Recurrence-free and overall survival at 5 and 10 years for patients with a positive STSM was 29 and 22%, and 29 and 11%, respectively (p < 0.001). A positive STSM increased the risk of recurrence by threefold and the overall risk of death by 2.6 times. Only nine patients (1%) without evidence of nodal involvement had a positive STSM with a worse survival compared to those same pathologic subgroup and negative STSM. Nine patients (2%) with lymph node tumor involvement had positive STSM and also demonstrated significantly worse survival.
CONCLUSION: Although a positive STSM was present in only 1% of patients undergoing a RC for TCC of the bladder, it was found to be an independent risk factor for advanced disease, lymph node involvement and tumor progression with worse survival. A dedicated effort should be made to avoid a positive STSM at the time of RC.

Entities:  

Mesh:

Year:  2008        PMID: 19020884     DOI: 10.1007/s00345-008-0345-1

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  15 in total

1.  Pathologic evaluation of radical cystectomy specimens: a cooperative group report.

Authors:  Harry W Herr; James R Faulkner; H Barton Grossman; E David Crawford
Journal:  Cancer       Date:  2004-06-01       Impact factor: 6.860

2.  Surgical benchmarks for the treatment of invasive bladder cancer.

Authors:  Eila C Skinner; John P Stein; Donald G Skinner
Journal:  Urol Oncol       Date:  2007 Jan-Feb       Impact factor: 3.498

3.  Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

Authors:  J P Stein; G Lieskovsky; R Cote; S Groshen; A C Feng; S Boyd; E Skinner; B Bochner; D Thangathurai; M Mikhail; D Raghavan; D G Skinner
Journal:  J Clin Oncol       Date:  2001-02-01       Impact factor: 44.544

4.  Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years.

Authors:  A Bergkvist; A Ljungqvist; G Moberger
Journal:  Acta Chir Scand       Date:  1965-10

5.  Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy.

Authors:  Stephan Madersbacher; Werner Hochreiter; Fiona Burkhard; George N Thalmann; Hansjörg Danuser; Regula Markwalder; Urs E Studer
Journal:  J Clin Oncol       Date:  2003-02-15       Impact factor: 44.544

6.  Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report.

Authors:  Harry Herr; Cheryl Lee; Sam Chang; Seth Lerner
Journal:  J Urol       Date:  2004-05       Impact factor: 7.450

Review 7.  Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer.

Authors:  Cora N Sternberg; S Machele Donat; Joaquim Bellmunt; Randall E Millikan; Walter Stadler; Pieter De Mulder; Amir Sherif; Hans von der Maase; Taiji Tsukamoto; Mark S Soloway
Journal:  Urology       Date:  2007-01       Impact factor: 2.649

8.  Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.

Authors:  H Barton Grossman; Ronald B Natale; Catherine M Tangen; V O Speights; Nicholas J Vogelzang; Donald L Trump; Ralph W deVere White; Michael F Sarosdy; David P Wood; Derek Raghavan; E David Crawford
Journal:  N Engl J Med       Date:  2003-08-28       Impact factor: 91.245

9.  Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure.

Authors:  John P Stein; Donald G Skinner
Journal:  World J Urol       Date:  2006-03-04       Impact factor: 4.226

10.  Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.

Authors:  Zohar A Dotan; Kathryn Kavanagh; Ofer Yossepowitch; Matt Kaag; Semra Olgac; Machele Donat; Harry W Herr
Journal:  J Urol       Date:  2007-10-22       Impact factor: 7.450

View more
  12 in total

1.  [Propensity-matched comparison of laparoscopic and open radical cystectomy for female patients with bladder cancer].

Authors:  H W Huang; B Yan; M X Shang; L B Liu; H Hao; Z J Xi
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-08-18

2.  Surgical control and margin status after robotic and open cystectomy in high-risk cases: Caution or equivalence?

Authors:  Pranav Sharma; Kamran Zargar-Shoshtari; Michael A Poch; Julio M Pow-Sang; Wade J Sexton; Philippe E Spiess; Scott M Gilbert
Journal:  World J Urol       Date:  2016-08-05       Impact factor: 4.226

3.  Dataset for the reporting of carcinoma of the bladder-cystectomy, cystoprostatectomy and diverticulectomy specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Authors:  E Compérat; J R Srigley; F Brimo; B Delahunt; M Koch; A Lopez-Beltran; V Reuter; H Samaratunga; J H Shanks; T Tsuzuki; T van der Kwast; M Varma; F Webster; D Grignon
Journal:  Virchows Arch       Date:  2020-01-08       Impact factor: 4.064

4.  Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes.

Authors:  Bernard H Bochner; Guido Dalbagni; Karim H Marzouk; Daniel D Sjoberg; Justin Lee; Sheri M Donat; Jonathan A Coleman; Andrew Vickers; Harry W Herr; Vincent P Laudone
Journal:  Eur Urol       Date:  2018-05-18       Impact factor: 20.096

5.  Risk stratification of survival by lymphovascular invasion, pathological stage, and surgical margin in patients with bladder cancer treated with radical cystectomy.

Authors:  Tatsuo Gondo; Jun Nakashima; Choichiro Ozu; Yoshio Ohno; Yutaka Horiguchi; Kazunori Namiki; Kunihiko Yoshioka; Makoto Ohori; Tadashi Hatano; Masaaki Tachibana
Journal:  Int J Clin Oncol       Date:  2011-09-07       Impact factor: 3.402

6.  Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial.

Authors:  Bernard H Bochner; Guido Dalbagni; Daniel D Sjoberg; Jonathan Silberstein; Gal E Keren Paz; S Machele Donat; Jonathan A Coleman; Sheila Mathew; Andrew Vickers; Geoffrey C Schnorr; Michael A Feuerstein; Bruce Rapkin; Raul O Parra; Harry W Herr; Vincent P Laudone
Journal:  Eur Urol       Date:  2014-12-08       Impact factor: 20.096

7.  Laparoscopic radical cystectomy with extracorporeal ileal neobladder for muscle-invasive urothelial carcinoma of the bladder: technique and short-term outcomes.

Authors:  Christopher Springer; Nasreldin Mohammed; Stefano Alba; Gerit Theil; Vincenzo Maria Altieri; Paolo Fornara; Francesco Greco
Journal:  World J Urol       Date:  2013-07-02       Impact factor: 4.226

8.  Risk factors associated with positive surgical margins' location at radical cystectomy and their impact on bladder cancer survival.

Authors:  Francesco Claps; Maaike W van de Kamp; Roman Mayr; Peter J Bostrom; Joost L Boormans; Markus Eckstein; Laura S Mertens; Egbert R Boevé; Yann Neuzillet; Maximilian Burger; Damien Pouessel; Carlo Trombetta; Bernd Wullich; Theo H van der Kwast; Arndt Hartmann; Yves Allory; Yair Lotan; Shahrokh F Shariat; Tahlita C M Zuiverloon; M Carmen Mir; Bas W G van Rhijn
Journal:  World J Urol       Date:  2021-07-01       Impact factor: 4.226

Review 9.  Robotic versus open radical cystectomy: an updated systematic review and meta-analysis.

Authors:  Leilei Xia; Xianjin Wang; Tianyuan Xu; Xiaohua Zhang; Zhaowei Zhu; Liang Qin; Xiang Zhang; Chen Fang; Minguang Zhang; Shan Zhong; Zhoujun Shen
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

10.  Radical cystectomy with pelvic lymphadenectomy: pathologic, operative and morbidity outcomes in a Brazilian cohort.

Authors:  Renato B Corradi; Gustavo Jaime Climaco Galvao; Gabriel M Oliveira; Vinicius F Carneiro; Wadson Gomes Miconi; Paulo Guilherme Oliveira Salles; Walter Luiz Ribeiro Cabral; Carlos Corradi; Andre Lopes Lopes Salazar
Journal:  Int Braz J Urol       Date:  2016 May-Jun       Impact factor: 1.541

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.